Press Releases
Site - Investor Relations
Predictive Oncology Strengthens Business with Appointment of a Chief Scientific Officer and Consolidation and Expansion of its Research and Development Arm
In this newly created role,
“Dr. Kirshner is a highly-qualified and well-respected scientific leader who understands the core technical and commercial value of each of the company’s product lines,” said
Dr. Kirshner’s academic experience includes training at the
Dr. Kirshner’s role also includes overseeing the consolidation of POAI’s TumorGenesis division, which will be moved to the company’s flagship
“By consolidating and growing our research and development capabilities, we will be better able to serve pharmaceutical and biotech companies looking to bring more effective cancer treatments to market,” noted
POAI expects the process to be completed by
About
Public Relations Contact:
630-566-2003
tferguson@predictive-oncology.com
Investor Relations Contact:
(404) 995-6671
kpinder@landoncapital.net
Forward-Looking Statements:
Certain matters discussed in this release contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties and assumptions about our operations and the investments we make. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, changes in management, plans and objectives of management are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “would,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors including, among other things, factors discussed under the heading “Risk Factors” in our filings with the SEC. Except as expressly required by law, the Company disclaims any intent or obligation to update these forward-looking statements.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/09b22a63-d158-4b3c-ae20-0bba4fc0409c
Source: Predictive Oncology Inc.